Cargando…

AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning

BACKGROUND: Rare tumors are diagnostic challenges for pathologists. Thymic epithelial tumors (TETs) are heterogenous and their treatment strategies vary according to histological subgroup. Previous work has shown that a second pathological opinion may result in a change in diagnosis for more than ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolezal, James M., Guo, Wenji, Bestvina, Christine, Vokes, Everett, Donington, Jessica, Husain, Aliya, Garassino, Marina Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792820/
http://dx.doi.org/10.21037/med-22-ab012
_version_ 1784859717052399616
author Dolezal, James M.
Guo, Wenji
Bestvina, Christine
Vokes, Everett
Donington, Jessica
Husain, Aliya
Garassino, Marina Chiara
author_facet Dolezal, James M.
Guo, Wenji
Bestvina, Christine
Vokes, Everett
Donington, Jessica
Husain, Aliya
Garassino, Marina Chiara
author_sort Dolezal, James M.
collection PubMed
description BACKGROUND: Rare tumors are diagnostic challenges for pathologists. Thymic epithelial tumors (TETs) are heterogenous and their treatment strategies vary according to histological subgroup. Previous work has shown that a second pathological opinion may result in a change in diagnosis for more than half of cases, with a potential treatment shift in 44%. The aim of this study is to assess the feasibility of using artificial intelligence and deep learning to classify TETs, which could be used to help improve pathologist diagnostic consistency for these challenging tumors. METHODS: Digital diagnostic hematoxylin and eosin (H&E) stained slides of tumors for 103 patients with thymoma type A, AB, B1, B2, and B3 were downloaded from The Cancer Genome Atlas (TCGA). An Xception-based deep convolutional neural network model was trained on slide images at 10× magnification to predict histologic subtype as an ordinal variable in three-fold cross-validation. Hyperparameters were taken from previously published experiments, and no additional hyperparameter tuning was performed to reduce the risk of overfitting. Validation predictions from each cross-fold were aggregated and compared between groups using analysis of variance (ANOVA) and one-sided t-tests with Bonferroni correction for multiple comparisons. Model activations at the post-convolutional layer for validation images in the first cross-fold were visualized with uniform manifold approximation and projection (UMAP) dimensionality reduction to better understand the spatial relationship between learned image features. RESULTS: Deep learning predictions among the TET subtypes were significantly different by ANOVA (P<0.0001) and correlated with the ordinal labels (R-squared =0.39). Thymoma A and AB subtypes were distinguished from both B1 and B2/B3 (P=0.023 and <0.001, respectively), and B1 tumors were distinguished from B2/B3 (P=0.011). Analysis of post-convolutional layer activations revealed an axis of transition through the ordinal variables, providing evidence that the deep learning model learned image features on a morphologic spectrum. CONCLUSIONS: This is the first example in TETs that deep learning can discriminate between TET histologic subtypes using digital H&E slides. We aim to further validate the algorithm with a multi-institution dataset from centers of expertise to improve the ability to distinguish thymoma subtypes.
format Online
Article
Text
id pubmed-9792820
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97928202022-12-30 AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning Dolezal, James M. Guo, Wenji Bestvina, Christine Vokes, Everett Donington, Jessica Husain, Aliya Garassino, Marina Chiara Mediastinum Abstract BACKGROUND: Rare tumors are diagnostic challenges for pathologists. Thymic epithelial tumors (TETs) are heterogenous and their treatment strategies vary according to histological subgroup. Previous work has shown that a second pathological opinion may result in a change in diagnosis for more than half of cases, with a potential treatment shift in 44%. The aim of this study is to assess the feasibility of using artificial intelligence and deep learning to classify TETs, which could be used to help improve pathologist diagnostic consistency for these challenging tumors. METHODS: Digital diagnostic hematoxylin and eosin (H&E) stained slides of tumors for 103 patients with thymoma type A, AB, B1, B2, and B3 were downloaded from The Cancer Genome Atlas (TCGA). An Xception-based deep convolutional neural network model was trained on slide images at 10× magnification to predict histologic subtype as an ordinal variable in three-fold cross-validation. Hyperparameters were taken from previously published experiments, and no additional hyperparameter tuning was performed to reduce the risk of overfitting. Validation predictions from each cross-fold were aggregated and compared between groups using analysis of variance (ANOVA) and one-sided t-tests with Bonferroni correction for multiple comparisons. Model activations at the post-convolutional layer for validation images in the first cross-fold were visualized with uniform manifold approximation and projection (UMAP) dimensionality reduction to better understand the spatial relationship between learned image features. RESULTS: Deep learning predictions among the TET subtypes were significantly different by ANOVA (P<0.0001) and correlated with the ordinal labels (R-squared =0.39). Thymoma A and AB subtypes were distinguished from both B1 and B2/B3 (P=0.023 and <0.001, respectively), and B1 tumors were distinguished from B2/B3 (P=0.011). Analysis of post-convolutional layer activations revealed an axis of transition through the ordinal variables, providing evidence that the deep learning model learned image features on a morphologic spectrum. CONCLUSIONS: This is the first example in TETs that deep learning can discriminate between TET histologic subtypes using digital H&E slides. We aim to further validate the algorithm with a multi-institution dataset from centers of expertise to improve the ability to distinguish thymoma subtypes. AME Publishing Company 2022-12-30 /pmc/articles/PMC9792820/ http://dx.doi.org/10.21037/med-22-ab012 Text en 2022 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Abstract
Dolezal, James M.
Guo, Wenji
Bestvina, Christine
Vokes, Everett
Donington, Jessica
Husain, Aliya
Garassino, Marina Chiara
AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title_full AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title_fullStr AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title_full_unstemmed AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title_short AB012. Automated histologic subtyping of thymic epithelial tumors with deep learning
title_sort ab012. automated histologic subtyping of thymic epithelial tumors with deep learning
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792820/
http://dx.doi.org/10.21037/med-22-ab012
work_keys_str_mv AT dolezaljamesm ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT guowenji ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT bestvinachristine ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT vokeseverett ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT doningtonjessica ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT husainaliya ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning
AT garassinomarinachiara ab012automatedhistologicsubtypingofthymicepithelialtumorswithdeeplearning